Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9384

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 0143-9384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fosaprepitant For Injection 1)

Chemical structure of fosaprepitant dimeglumine, showing the molecular arrangement of its active components as presented in the image.*

FDA Label Image

Label (Fosaprepitant For Injection 2)

Label for Fosaprepitant Dimeglumine injection, powder, lyophilized for solution for intravenous use, 150 mg per vial. The single-dose vial label includes storage instructions to keep refrigerated at 2°C to 8°C and stability information after reconstitution. It is manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Carton (Fosaprepitant For Injection 3)

The packaging label for Fosaprepitant for Injection, 150 mg per vial, a sterile lyophilized powder for intravenous injection by Hikma Pharmaceuticals USA Inc. The label states reconstitution instructions using 5 mL of 0.9% Sodium Chloride for Injection and includes warnings against use with solutions containing divalent cations. The product is single dose, with discard instructions for unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.